CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number | Lead Group | Study Title | CIRB | Study Status |
|---|---|---|---|---|
| S2013 | SWOG | Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study | Cancer Prevention and Control CIRB | Available to Open |
| NRG-GY012 | NRG | A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women with Recurrent, Persistent or Metastatic Endometrial Cancer | Adult CIRB - Late Phase Emphasis | Available to Open |
| 10546 | ETCTN | Phase I Study Targeting DNA Methyltransferases in Metastatic Triple-Negative Breast Cancer | Adult CIRB - Early Phase Emphasis | Available to Open |
| 10214 | ETCTN | Immune Checkpoint Blockade for Kidney Transplant Recipients with Selected Unresectable or Metastatic Cancers | Adult CIRB - Early Phase Emphasis | Available to Open |
| EA1131 | ECOG-ACRIN | A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy | Adult CIRB - Late Phase Emphasis | Available to Open |
| 10005 | ETCTN | A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma | Adult CIRB - Early Phase Emphasis | Available to Open |
| WF-2202 | NCORP-Wake Forest University | Optimizing Psychosocial Intervention for Breast Cancer-related Sexual Morbidity: The Sexual Health and Intimacy Education (SHINE) Trial | Cancer Prevention and Control CIRB | Available to Open |
| S1820 | SWOG | A Randomized Trial of the Altering Intake, Managing Symptoms Intervention for Bowel Dysfunction in Rectal Cancer Survivors Compared to a Healthy Living Education Control: A Feasibility and Preliminary Efficacy Study (AIMS-RC) | Cancer Prevention and Control CIRB | Available to Open |
| EA2183 | ECOG-ACRIN | A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA) | Adult CIRB - Late Phase Emphasis | Available to Open |
| S1403 | SWOG | A Randomized Phase II Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients with Advanced, EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) (BI 1200.124) | Adult CIRB - Late Phase Emphasis | Available to Open |